Cisatracurium Ups Some ARDS Outcomes Versus Vecuronium

This article originally appeared here.
Share this content:
Cisatracurium Ups Some ARDS Outcomes Versus Vecuronium
Cisatracurium Ups Some ARDS Outcomes Versus Vecuronium

WEDNESDAY, Dec. 20, 2017 (HealthDay News) -- Among patients with acute respiratory distress syndrome (ARDS), cisatracurium does not improve mortality versus vecuronium but is associated with improvements in other outcomes, according to a study published online in the American Journal of Respiratory and Critical Care Medicine.

Peter D. Sottile, M.D., from the University of Colorado School of Medicine in Aurora, and colleagues compared outcomes with cisatracurium and vecuronium in patients at risk for and with ARDS. The authors used propensity matching to balance patient- and hospital-specific factors in a cohort of 3,082 patients (1,901 per group).

The researchers found that there was no significant between-group difference in mortality (odds ratio, 0.932; P = 0.4) or hospital days (−0.66; P = 0.411). Fewer ventilator days (−1.01; P = 0.005) and intensive care unit days (−0.98; P = 0.28) were seen for patients treated with cisatracurium; however, they were equally likely to be discharged home (odds ratio, 1.19; P = 0.056).

"When compared to vecuronium, cisatracurium was not associated with a difference in mortality, but was associated with improvements in other clinically important outcomes," the authors write. "These data suggest that cisatracurium may be the preferred neuromuscular blocking agent for patients at risk for and with ARDS."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Wait Times Have Improved in VA Health Care System

Wait Times Have Improved in VA Health Care ...

Wait times similar to private sector in 2014 but shorter overall and in some specialties in 2017

Medication Treatment for Substance Abuse Up in Facilities

Medication Treatment for Substance Abuse Up in Facilities

2007 to 2016 saw increase in use of medication treatment, reaching 36.1 percent in 2016

Mindfulness, Stress Linked to Menopausal Symptoms

Mindfulness, Stress Linked to Menopausal Symptoms

Link between mindfulness and symptoms more robust in women experiencing higher stress

is free, fast, and customized just for you!




Already a member?

Sign In Now »